“Knowledge is the antidote to fear."

How P-glycoprotein acts as a molecular bouncer, causing treatment resistance by pumping chemotherapy out of cancer cells before it can work.
How a repurposed medicine acts as a sensitizing agent, inhibiting that efflux pump to keep treatment inside the cells — potentially increasing sensitivity up to 60-fold.
Why I now point people to the Ivermectin + Mebendazole stack, and how to talk to your oncologist about drug retention with total confidence.
Hey Crew!
I've been thinking about a question that quietly haunts so many people in this community: what happens if the treatment stops working?
When I was going through my own chemotherapy, I felt that fear in my bones. The confusion, the despair, the sense that I was doing everything right and still losing ground. So today I want to hand you something that took me far too long to learn — a strategy for the exact moment treatment starts to stall.
I believe we have to be brave and advocate for ourselves, exploring every option that lets us take an active role in our recovery. We need to be rockstars about our own healing.
So let's talk about the Efflux Pump Strategy.

The Science
It's one of the most heartbreaking things a patient can hear: "The treatment isn't working anymore."
In the medical world they call this multi-drug resistance (MDR), and it's responsible for more than 90% of deaths in patients undergoing chemotherapy.
Here's why it happens. Your cancer cells are smart. They want to survive, so they build a defense mechanism called P-glycoprotein (MDR1). Think of it like a molecular bouncer — an efflux pump whose only job is to stand at the door of the cancer cell and kick the chemo back out before it can work.
When those bouncers are working overtime, you can pour the most intensive treatments in the world into your body and they simply won't stay inside the cells. This is where so many of us feel stuck — doing the hard work of traditional treatment while the cells lock us out.
The Strategy: Lock the Bouncer in a Closet
What if we could just lock that bouncer in a closet? That's exactly what recent pharmacology reviews suggest about a Nobel Prize–winning medicine, Ivermectin.
While it's famous as an anti-parasitic, researchers are now looking at it as a potent sensitizing agent. It appears to inhibit the P-glycoprotein bouncer — essentially locking the door from the inside so the pump can't throw the chemo out.
The lab results have been stunning. In a landmark study at Strasbourg University, multidrug-resistant leukemia cells became 60-fold more sensitive to treatment when Ivermectin was used alongside standard chemotherapy. It was also roughly 4-fold more potent at reversing resistance than other common inhibitors like cyclosporin A.
We aren't replacing traditional treatment here — we're making it work better, helping the medicine your oncologist prescribed actually stay in the cell long enough to trigger apoptosis (cell death).

Why I Now Recommend the Ivermectin + Mebendazole Stack
I love a strategy that attacks from every angle — and that's exactly why I've moved from Ivermectin alone to the Ivermectin + Mebendazole stack at Fierce Health.
Ivermectin does more than block the bouncer. It's been shown to:
Starve the tumor by inhibiting Mitochondrial Complex I, cutting off the energy (ATP) cancer cells need to grow and power their defense pumps.
Trigger self-digestion, forcing cancer cells into nonprotective autophagy where they consume themselves beyond repair.
Target the roots, disrupting the "stemness" of cancer stem cells by downregulating genes like NANOG and SOX2 that drive recurrence.
Mebendazole comes at the problem from a different direction — disrupting the cancer cell's microtubules (its internal scaffolding) and adding another metabolic stressor. Together, the two are a true multi-targeted approach: one keeps treatment in the cell, while both work to starve and destabilize the cell itself.
The Fierce Health protocol is prescription-only and high-purity, reviewed by licensed providers and dispensed by a 50-state licensed U.S. pharmacy. Both are generally well-tolerated with low toxicity in humans, even alongside concurrent chemotherapy. (Ivermectin is best taken in the morning on an empty stomach for maximum absorption.)

How to Talk to Your Oncologist
I know it can be intimidating to bring up repurposed options with your lead oncologist. You don't want to be judged or feel like you're going behind their back.
My advice? Use the language of the lab. Position the stack as a sensitizing agent or adjunct therapy designed to enhance the standard of care. Tell them you're concerned about P-glycoprotein (ABCB1) acting as an efflux pump, and that you'd like to discuss strategies to increase drug retention.
Most doctors want what's best for you — they're just often stuck in a cookie-cutter process. When you show up as an educated advocate, you change the dynamic.
If you want help preparing for that conversation, you can book a free consultation with the Fierce Health team. They'll walk you through the mechanism so you can walk into your next appointment with total confidence.
Remember, Crew: there's no such thing as perfect. If all you can do today is swap one processed snack for real food, or spend five minutes in prayer, that is a monumental win. Your body has a beautiful internal system that wants to heal when you give it what it needs.
Keep going.
This is education, not medical advice. Always talk to your oncologist before changing your treatment plan.
With heart, The Cancer Crew

Help us make the next issue even better by picking the option that fits you best.
Must-Reads You Might’ve Missed







